CClinicalTrials.gg
TerminatedNCT03264092Updated Apr 1, 2021Results posted

Comparison of Three Tissue Acquiring Techniques During EUS Guided Biopsies of Solid Tumors.

An interventional study of Endoscopic ultrasound guided fine needle biopsy in Solid Tumor, sponsored by Texas Tech University Health Sciences Center, El Paso. Terminated at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2021-04-01.

Sponsored by Texas Tech University Health Sciences Center, El Paso · Not applicable, Interventional, and Diagnostic

Why this study was terminated
Preliminary analysis of the results showed no statistically significant difference
Phase
Not applicable
Study type
Interventional
Enrollment
55
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The study's aim is to prospectively compare three different tissue acquisition techniques during EUS guided solid lesions biopsies.

Read the detailed description

Endoscopic ultrasound guided fine-needle aspiration (EUS-FNA) has been used since 1990's for the diagnosis and staging of esophageal, gastric, duodenal, pancreatobiliary, rectal mediastinal lesions and intra-abdominal lymphadenopathy. Studies have shown a variable range of specimen adequacy when performing pancreatic biopsies with the standard fine needle aspiration (FNA) needles with this modality. There are several factors that affect the overall diagnostic yield of this procedure, such as endosonographer experience, presence of cytopathologist during the procedure, the needle diameter and the number of passes. In this study we will compare the yield of recently available fine biopsy needles (FNB) using three different techniques to obtain samples from solid lesions. The three techniques to be compared in this study are: stylet slow pull (SP) vs dry suction (DS) vs wet suction (WS).

wall cells.

In the "suction technique" the stylet of the needle can be left in place or removed before puncturing the lesion. Once the needle is inside the target, negative pressure is applied through a 10 or 20 cc syringe connected to the needle.

The wet suction technique consists of flushing of the needle with 5 ml of saline solution to replace the column of air within the lumen of needle with saline solution before needle aspiration. Once the needle is flushed, negative pressure is applied with a 10 or 20 cc syringe connected to the needle.

In the slow pull technique, the stylet is left in place in the needle and is slightly retracted prior to puncturing the lesion. Once the needle is inside the target, the stylet is pushed completely into the needle to remove any contaminant cells and several back and forth movements are done while slowly withdrawing the stylet.

02

Conditions studied

  • Solid Tumor

Browse trials for

03

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Ages between 18-80 years old
  2. Sex: male or female
  3. Patients who require EUS and tissue sampling of solid solid lesions (size >1 cm) anywhere in the following locations: lymph nodes, stomach, esophagus, colon, small intestine, pancreas, liver, spleen or kidney.
  4. Patients who are able to give consent

Exclusion criteria

Exclusion Criteria:

  1. Pregnant female
  2. Coagulation disorders (platelets \< 50,000/mm3, INR > 2)
  3. Patients with acute pancreatitis in the immediate 2 weeks prior to the procedure.
  4. Cardiorespiratory dysfunction that precludes sedation.
  5. Unable to provide informed consent
04

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
55 participants (actual)

Study arms

  • Experimental
    Wet suction

    This arm will include all the patients that will get an endoscopic ultrasound guided fine needle biopsy done with the wet suction technique

    Procedure: Endoscopic ultrasound guided fine needle biopsy

  • Experimental
    Dry suction

    This arm will include all the patients that will get and endoscopic ultrasound guided fine needle biopsy done with the dry suction technique

    Procedure: Endoscopic ultrasound guided fine needle biopsy

  • Experimental
    Slow pull

    This arm will include all the patients that will get an endoscopic ultrasound guided fine needle biopsy done with the slow pull technique

    Procedure: Endoscopic ultrasound guided fine needle biopsy

Interventions

  • ProcedureEndoscopic ultrasound guided fine needle biopsy

    Using the echoendoscope the lesion is identified and the needle is inserted in it to obtain a biopsy also under sonographic guidance

05

What researchers measure

Primary outcomes

  1. Cellularity of Specimens Obtained by Each Individual Technique Based on Cellularity Score

    0: inadequate 1. limited cytological dx 2. adquate cytological dx 3. limited histological dx 4. adequate histological dx with low quality 5. adequate histological dx with high quality

    Time frame: 2 hours

Secondary outcomes

  1. Blood Contamination Score of Each Specimen Obtained

    This is based on the following scale 1. Blood present 2. Blood clots present

    Time frame: 2 hours

  2. Number of Participants Stratified Per the Number of Diagnostic Passes Required

    This indicates which out of the 3 passes provided enough tissue for diagnosis. If after 3 passes not enough tissue was obtained, the doctor was free to use the technique of his preference outside of the protocol.

    Time frame: 2 hours

06

Results

Posted Apr 1, 2021

Participant flow

The study was terminated early given the difficulty we experienced enrolling patients.

Participant flow — Overall Study
MilestoneWet SuctionDry SuctionSlow Pull
Started172018
Completed172018
Not completed000

Outcome measures

PrimaryCellularity of Specimens Obtained by Each Individual Technique Based on Cellularity Score

0: inadequate 1. limited cytological dx 2. adquate cytological dx 3. limited histological dx 4. adequate histological dx with low quality 5. adequate histological dx with high quality

Time frame:
2 hours
Reported as:
Mean · units on a scale
Cellularity of Specimens Obtained by Each Individual Technique Based on Cellularity Score
units on a scaleWet SuctionDry SuctionSlow Pull
Cellularity of Specimens Obtained by Each Individual Technique Based on Cellularity Score2.94 ± 0.753.55 ± 0.763.28 ± 0.89
Statistical analysis
  • Wet Suction vs Dry Suction vs Slow Pull · Fisher Exact · p = 0.18
SecondaryBlood Contamination Score of Each Specimen Obtained

This is based on the following scale 1. Blood present 2. Blood clots present

Time frame:
2 hours
Reported as:
Number · participants
Blood Contamination Score of Each Specimen Obtained
participantsWet SuctionDry SuctionSlow Pull
Blood present171918
Blood clot present010
Statistical analysis
  • Wet Suction vs Dry Suction vs Slow Pull · Fisher Exact · p = 0.41
SecondaryNumber of Participants Stratified Per the Number of Diagnostic Passes Required

This indicates which out of the 3 passes provided enough tissue for diagnosis. If after 3 passes not enough tissue was obtained, the doctor was free to use the technique of his preference outside of the protocol.

Time frame:
2 hours
Reported as:
Number · participants
Number of Participants Stratified Per the Number of Diagnostic Passes Required
participantsWet SuctionDry SuctionSlow Pull
Diagnostic pass 16117
Diagnostic pass 2754
Diagnostic pass 3336
Diagnostic pass 4100
Diagnostic pass 5010
Diagnostic pass 6001
Statistical analysis
  • Wet Suction vs Dry Suction vs Slow Pull · Fisher Exact · p = 0.45

Adverse events

Collected over 2 hours. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Wet Suction0/17 (0%)0/17 (0%)0/17 (0%)
Dry Suction0/20 (0%)0/20 (0%)3/20 (15%)
Slow Pull0/18 (0%)0/18 (0%)0/18 (0%)
Most frequent other events
Most frequent other events
EventWet SuctionDry SuctionSlow Pull
BleedingGastrointestinal disorders0/173/200/18

Baseline characteristics

Age, Continuous
Age, Continuous(years)Wet SuctionDry SuctionSlow PullTotal
Mean69 ± 1364 ± 1466 ± 1066 ± 13
Sex: Female, Male
Sex: Female, Male(Participants)Wet SuctionDry SuctionSlow PullTotal
Female107623
Male7131232
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Wet SuctionDry SuctionSlow PullTotal
Hispanic or Latino13171545
Not Hispanic or Latino43310
Unknown or Not Reported0000
Region of Enrollment
Region of Enrollment(participants)Wet SuctionDry SuctionSlow PullTotal
United States17201855
07

Study locations

1 site
  • Texas Tech university Health Sciences Center El Paso
    El Paso, Texas 79905, United States
08

References and documents

Publications

  • Yamao K, Sawaki A, Mizuno N, Shimizu Y, Yatabe Y, Koshikawa T. Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNAB): past, present, and future. J Gastroenterol. 2005 Nov;40(11):1013-23. doi: 10.1007/s00535-005-1717-6. PubMed 16322944 ↗
  • Puri R, Vilmann P, Saftoiu A, Skov BG, Linnemann D, Hassan H, Garcia ES, Gorunescu F. Randomized controlled trial of endoscopic ultrasound-guided fine-needle sampling with or without suction for better cytological diagnosis. Scand J Gastroenterol. 2009;44(4):499-504. doi: 10.1080/00365520802647392. PubMed 19117242 ↗
  • Mendoza Ladd A, Casner N, Cherukuri SV, Garcia C, Padilla O, Dwivedi A, Hakim N. Fine Needle Biopsies of Solid Pancreatic Lesions: Tissue Acquisition Technique and Needle Design Do Not Impact Specimen Adequacy. Dig Dis Sci. 2022 Sep;67(9):4549-4556. doi: 10.1007/s10620-021-07316-4. Epub 2021 Dec 2. PubMed 34859313 ↗

Study documents

  • Protocol and statistical analysis plan · May 8, 2020

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Registry details

Key details

Study ID
NCT03264092
Lead sponsor
Texas Tech University Health Sciences Center, El Paso
Responsible party
Antonio Mendoza-Ladd (Assistant Professor of Medicine, Texas Tech University Health Sciences Center, El Paso) — Principal investigator
First posted
Aug 28, 2017
Start date
Sep 11, 2017
Primary completion
Oct 1, 2020
Completion
Oct 1, 2020
Results posted
Apr 1, 2021
Last update
Apr 1, 2021

Study contacts

Antonio Mendoza Ladd, MD
principal investigator · Texas Tech University Health Sciences Center, El Paso

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion